Breast Cancer Clinical Trial

A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer

Summary

The purpose of this study is to develop a digital strategy to increase awareness about lung cancer screening among women who are eligible to receive it. The digital strategy involves email communications and LungTalk, a web-based (accessed through the Internet) health communication tool that uses text, audio, video, and animation to increase awareness and knowledge about lung cancer screening. This study will focus on women who have recently received a screening mammogram.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

LDCT screening-eligible women who received a BiRADS 1 (negative) or 2 (benign/non-cancerous finding) result from a screening mammogram in the last 7 days
Age 50-80 years
≥ 20-pack-year smoking history of combustible cigarettes as per self report
Women who currently smoke or quit within past 15 years as per self report
Lung screening naïve as per self-report

Exclusion Criteria:

Lung cancer diagnosis
Chest CT within the last 12 months

Study is for people with:

Breast Cancer

Phase:

Early Phase 1

Estimated Enrollment:

30

Study ID:

NCT04848961

Recruitment Status:

Active, not recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 8 Locations for this study

See Locations Near You

Hartford Healthcare Cancer Institute @ Hartford Hospital
Hartford Connecticut, 06102, United States
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge New Jersey, 07920, United States
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
Middletown New Jersey, 07748, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale New Jersey, 07645, United States
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)
Commack New York, 11725, United States
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Harrison New York, 10604, United States
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Uniondale New York, 11553, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Early Phase 1

Estimated Enrollment:

30

Study ID:

NCT04848961

Recruitment Status:

Active, not recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider